Skip to main content
Journal cover image

Gene expression-based signatures of chemosensitivity and oncogenic pathway deregulation provide a novel approach to breast cancer therapeutics.

Publication ,  Conference
Potti, A; Dressman, HK; Bild, AH; Nevins, JR; Marcom, PK
Published in: BREAST CANCER RESEARCH AND TREATMENT
January 1, 2006

Duke Scholars

Published In

BREAST CANCER RESEARCH AND TREATMENT

ISSN

0167-6806

Publication Date

January 1, 2006

Volume

100

Start / End Page

S278 / S278

Location

San Antonio, TX

Publisher

SPRINGER

Conference Name

29th Annual San Antonio Breast Cancer Symposium

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Potti, A., Dressman, H. K., Bild, A. H., Nevins, J. R., & Marcom, P. K. (2006). Gene expression-based signatures of chemosensitivity and oncogenic pathway deregulation provide a novel approach to breast cancer therapeutics. In BREAST CANCER RESEARCH AND TREATMENT (Vol. 100, pp. S278–S278). San Antonio, TX: SPRINGER.
Potti, A., H. K. Dressman, A. H. Bild, J. R. Nevins, and P. K. Marcom. “Gene expression-based signatures of chemosensitivity and oncogenic pathway deregulation provide a novel approach to breast cancer therapeutics.” In BREAST CANCER RESEARCH AND TREATMENT, 100:S278–S278. SPRINGER, 2006.
Potti A, Dressman HK, Bild AH, Nevins JR, Marcom PK. Gene expression-based signatures of chemosensitivity and oncogenic pathway deregulation provide a novel approach to breast cancer therapeutics. In: BREAST CANCER RESEARCH AND TREATMENT. SPRINGER; 2006. p. S278–S278.
Potti, A., et al. “Gene expression-based signatures of chemosensitivity and oncogenic pathway deregulation provide a novel approach to breast cancer therapeutics.BREAST CANCER RESEARCH AND TREATMENT, vol. 100, SPRINGER, 2006, pp. S278–S278.
Potti A, Dressman HK, Bild AH, Nevins JR, Marcom PK. Gene expression-based signatures of chemosensitivity and oncogenic pathway deregulation provide a novel approach to breast cancer therapeutics. BREAST CANCER RESEARCH AND TREATMENT. SPRINGER; 2006. p. S278–S278.
Journal cover image

Published In

BREAST CANCER RESEARCH AND TREATMENT

ISSN

0167-6806

Publication Date

January 1, 2006

Volume

100

Start / End Page

S278 / S278

Location

San Antonio, TX

Publisher

SPRINGER

Conference Name

29th Annual San Antonio Breast Cancer Symposium

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences